320
Participants
Start Date
June 17, 2013
Primary Completion Date
January 31, 2020
Study Completion Date
January 31, 2022
TNF inhibitors
Synthetic DMARD(s)
Co-medication: Synthetic DMARDs
Synthetic DMARDs given as co-medication for TNF inhibitors as appropriate.
Martina Hansens Hospital AS, Sandvika
Department of Rheumatology, Sykehuset Østfold HF, Fredrikstad
Revmatismesykehuset AS, Lillehammer
Department of Rheumatology, Drammen Hospital, Vestre Viken HF, Drammen
Department of Rheumatology, Sørlandet Sykehus HF, Kristiansand
Department of Rheumatology, Haukeland University Hospital, Helse Bergen HF, Bergen
Department of Rheumatology, Helse Møre og Romsdal HF, Ålesund
Helgelandssykehuset, Mo i Rana, Mo i Rana
Universitetssykehuset Nord-Norge HF, Tromsø
Department of Rheumatology, Diakonhjemmet Hospital, Oslo
The Research Council of Norway
OTHER
South-Eastern Norway Regional Health Authority
OTHER
Diakonhjemmet Hospital
OTHER